IPOs - Spark Newswire

1 minute read

IPOs

Preview: Wytec International, Inc Set To IPO Tomorrow

Today, 10:18 AM

Wytec International, Inc (NASDAQ:WYTC) IPO will take place May, 06 on the NASDAQ exchange under the ticker WYTC. The company is offering shares at an expected price between $4.15 and $6.15 per share with an insider lock-up period of 180 days ending on November 02, 2022.

WYTC

2 minute read

IPOs
News

AIkido Pharma Reports Co. Partner For Securities Purchase Deal, Slinger Bag, Filed IPO To List On Nasdaq

By Benzinga Newsdesk

Today, 10:18 AM

Company's Flagship Product, The Slinger Bag, Top Rated Among 2022 Tennis Products NEW YORK, May 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today reported

AIKI

5 minute read

De Well Files for Hong Kong IPO, Flush With New Ties to Cainiao

By The Bamboo Works

Today, 10:18 AM

Key Takeaways: • Global logistics services provider De Well has filed for a Hong Kong IPO, aiming to boost its footprint on booming demand for cross-border e-commerce

AMZN

1 minute read

AIkido Pharma Reports Strategic Investment In Social Communications Platform, Discord, No Terms Disclosed; Press Release Says ‘Discord Reportedly Interviewing Investment Bankers About Going Public This Year’

By Benzinga Newsdesk

Today, 10:18 AM

AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today announced that the Company has secured an early equity interest in privately-held Discord, Inc. (https://discord.com/), a social

AIKI

1 minute read

UPDATE: Elon Musk Has Told Potential Investors He Could Stage Twitter IPO Within A Few Years

By Benzinga Newsdesk

Today, 10:18 AM

-Dow Jones

TWTR

2 minute read

Arm Removes Significant Obstacle Hindering IPO Aspirations: FT

By Anusuya Lahiri

Today, 10:18 AM

Softbank Group Corp (OTC:SFTBY) (OTC:SFTBF) owned Arm is on the verge of regaining control of its defector China joint…

SFTBF

1 minute read

Belite Bio Priced 6M ADS IPO @$6/ADS

By Charles Gross

Today, 10:18 AM

Belite Bio, Inc (NASDAQ: BLTE) ("Belite" or the "Company"), a clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases such as dry AMD and Stargardt disease, and metabolic diseases, today announced the pricing of its initial public offering of 6 million American Depositary Shares (

BLTE

1 minute read

Natural Killer Cell Therapy Focused-Cytovia Turns To SPAC Merger For Public Market Debut

By Vandana Singh

Today, 10:18 AM

About 14 months after inking a natural killer cell deal with Cellectis SA (NASDAQ:CLLS), Cytovia plans to list on NASDAQ via…

CLLS

4 minute read

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

By Shanthi Rexaline

Today, 10:18 AM

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering rate hike fears.

ABBV

1 minute read

SoftBank Wants Controlling Stake In Arm Post IPO – Read Why

By Anusuya Lahiri

Today, 10:18 AM

SoftBank Group Corp (OTC:SFTBY) (OTC:SFTBF) looks to retain a controlling stake in Arm Ltd after the planned IPO selling…

NVDA